
Axim Biotechnologies
(OTC) AXIM
Axim Biotechnologies Financials at a Glance
Market Cap
$1.46M
Revenue (TTM)
$0.00
Net Income (TTM)
-$1.05M
EPS (TTM)
-$0.00
P/E Ratio
-1.26
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$0.00
Volume
21,010
Open
$0.00
Price
$0.00
Volume
21,010
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.01
52-Week Range
$0.00 - $0.03
Estimated Earnings Date
Apr 13, 2026
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$0.00
Volume
21,010
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.01
52-Week Range
$0.00 - $0.03
Estimated Earnings Date
Apr 13, 2026
AXIM News

Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Axim Biotechnologies
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
John W. Huemoeller, II
Website
www.aximbiotech.comHeadquarters
San Diego, CA 92121, US
AXIM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
31%
Return on Assets
-16%
Earnings Yield
-79.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.46M
Shares Outstanding
340.46M
Volume
21.01K
Avg. Volume
143.32K
Financials (TTM)
Gross Profit
-$427.37K
Operating Income
-$1.32M
EBITDA
-$892.28K
Operating Cash Flow
-$686.21K
Capital Expenditure
$0.00
Free Cash Flow
-$686.21K
Cash & ST Invst.
$4.97K
Total Debt
$7.78M
Axim Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$108.13K
-787.2%
Gross Margin
0.00%
N/A
Market Cap
$1.46M
N/A
Market Cap/Employee
$244.00K
N/A
Employees
6
N/A
Net Income
$135.92K
+106.0%
EBITDA
$328.35K
+117.1%
Quarterly Fundamentals
Total Cash
$2.80K
-53.6%
Total Debt
$7.55M
+17.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.44M
+17.9%
Short Term Debt
$101.55K
-45.2%
Return on Assets
-15.97%
N/A
Return on Invested Capital
31.21%
N/A
Free Cash Flow
-$673.59K
-221.8%
Operating Cash Flow
-$673.59K
-221.8%






